{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:10:19Z","timestamp":1761718219783},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2011.12.137","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T17:37:26Z","timestamp":1337189846000},"page":"B98-B105","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Towards a meningitis free world\u2014Can we eliminate meningococcal meningitis?"],"prefix":"10.1016","volume":"30","author":[{"given":"Sue","family":"Davie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Glennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.137_bib0005","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/S0264-410X(00)00546-6","article-title":"The future of vaccines, immunisation concepts and practice","volume":"19","author":"Andr\u00e9","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0185","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.330.7506.1475","article-title":"The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases","volume":"330","author":"Ninis","year":"2005","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1099\/mic.0.2007\/014761-0","article-title":"Molecular epidemiology of meningococcal disease in England and Wales 1975\u20131995, before the introduction of serogroup C conjugate vaccines","volume":"154","author":"Russell","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0190","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1128\/JB.181.18.5551-5556.1999","article-title":"Population genetic and evolutionary approaches to the analysis of Neisseria meningitidis isolates belonging to the ET-5 complex","volume":"181","author":"Bygraves","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0195","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0035","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/IAI.72.10.5955-5962.2004","article-title":"Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design","volume":"72","author":"Urwin","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0882-4010(95)90093-4","article-title":"Whole blood model of meningococcal bacteraemia\u2014a method for exploring host-bacterial interactions","volume":"18","author":"Ison","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0200","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CVI.00230-06","article-title":"Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents","volume":"14","author":"Boutriau","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0210","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00006454-200111000-00010","article-title":"Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants","volume":"20","author":"Morley","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/IAI.66.1.213-217.1998","article-title":"Periplasmic superoxide dismutase in meningococcal pathogenicity","volume":"66","author":"Wilks","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1046\/j.1365-2958.2000.02061.x","article-title":"Auto-transporter A protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning","volume":"37","author":"Ait-Tahar","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.2001.02516.x","article-title":"Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis","volume":"41","author":"Hadi","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0220","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/IAI.73.8.4684-4693.2005","article-title":"T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease","volume":"73","author":"Robinson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1462-5822.2004.00471.x","article-title":"Activation of human meningeal cells is modulated by lipopolysaccharide (LPS) and non-LPS components of Neisseria meningitidis and is independent of Toll-like receptor (TLR)4 and TLR2 signalling","volume":"57","author":"Humphries","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-3083.2005.01671.x","article-title":"The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide","volume":"62","author":"Tiwana","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0225","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/JCM.00005-08","article-title":"Opa protein repertoires of disease-causing and carried meningococci","volume":"46","author":"Callaghan","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.gene.6364442","article-title":"Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease","volume":"9","author":"Callaghan","year":"2008","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0105","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1016\/j.vaccine.2011.07.060","article-title":"Testing the vaccine potential of PilV, PilX and ComP, minor subunits of Neisseria meningitidis type IV pili","volume":"29","author":"Cehovin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0235","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1016\/j.vaccine.2010.04.065","article-title":"Sequence conservation of pilus subunits in Neisseria meningitides","volume":"28","author":"Cehovin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/IAI.00968-08","article-title":"Identification of meningococcal genes necessary for colonization of human upper airway tissue","volume":"77","author":"Exley","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0245","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/IAI.73.4.2424-2432.2005","article-title":"Genetic diversity and carriage dynamics of Neisseria lactamica in infants","volume":"73","author":"Bennett","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0250","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/cid\/ciq065","article-title":"Nasopharyngeal colonisation by Nesserialactamica and induction of protective immunity against Neisseria meningitides","volume":"52","author":"Evans","year":"2011","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0255","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20072577","article-title":"A generic mechanism for enhanced resistance against bactericidal antibodies in Neisseria meningitides","volume":"205","author":"Uria","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2249.2007.03535.x","article-title":"Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease","volume":"151","author":"Baxendale","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/adc.2006.105916","article-title":"Effect of meningitis in infancy on school-leaving examination results","volume":"92","author":"de Louvois","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/PCC.0b013e3181ae785a","article-title":"Longer-term psychiatric adjustment of children and parents after meningococcal disease","volume":"10","author":"Garralda","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0150","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1542\/peds.2008-0581","article-title":"Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study","volume":"123","author":"Borg","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0155","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1542\/peds.2006-0502","article-title":"Does cause of deafness influence outcome after cochlear implantation in children","volume":"118","author":"Nikolopoulos","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(86)90124-8","article-title":"An outbreak of meningococal disease in Gloucestershire","volume":"2","author":"Cartright","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0265","unstructured":"Hilton M. Horror of Meningitis. The Independent. 13 June 2000."},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.12.137_bib0165","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1016\/j.vaccine.2010.02.034","article-title":"The United Kingdom Joint Committee on vaccination and immunisation","volume":"28","author":"Hall","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0170","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.324.7341.809","article-title":"Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales","volume":"324","author":"Trotter","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0175","series-title":"Abstract P092 presented at the 11th EMGM Congress","article-title":"Aftercare and support for children after meningitis and septicaemia: the parents\u2019 view","author":"Clark","year":"2011"},{"key":"10.1016\/j.vaccine.2011.12.137_bib0180","series-title":"Abstract P049 presented at the 11th EMGM Congress","article-title":"Potential coverage of English and Welsh group b isolates by an investigational meningococcal group B vaccine","author":"Findlow","year":"2011"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T19:36:54Z","timestamp":1594150614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":37,"alternative-id":["S0264410X12000163"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.137","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}